MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, CNTB made $16K in revenue. -$17,102K in net income. Net profit margin of -106887.50%.

Income Overview

Revenue
$16K
Net Income
-$17,102K
Net Profit Margin
-106887.50%
EPS
-$0.31
Unit: Thousand (K) dollars

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2024-12-31
License and collaboration revenue
16 -6,508
Research and development expense
11,110 -7,314
General and administrative expense
6,583 -4,807
Total operating expenses
17,693 -12,121
Loss from operations
-17,677 --5,613
Interest income
545 -1,113
Other income (expense)
-7 -649
Total other income, net
538 -1,762
Net loss before income tax
-17,139 -12,844 -3,851
Income tax expense
61 55 56
Net loss
-17,200 -12,899 -3,907
Foreign currency translation adjustments
87 236 -167
Unrealized gains on available-for-sale investments
11 -6 3
Comprehensive loss
-17,102 -12,669 -4,071
Basic net loss per ordinary share (in dollars per share)
-0.31 -0.23 -0.07
Diluted net loss per ordinary share (in dollars per share)
-0.31 -0.23 -0.07
Weighted-average ordinary shares outstanding, basic (in shares)
55,716,000 55,498,000 13,803,250
Weighted-average ordinary shares outstanding, diluted (in shares)
55,716,000 55,498,000 13,803,250
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$17,102K Unrealized gains onavailable-for-sale investments$11K Foreign currencytranslation adjustments$87K Net loss-$17,200K Interest income$545K Income tax expense$61K Net loss beforeincome tax-$17,139K Total other income,net$538K Other income(expense)-$7K Loss from operations-$17,677K License andcollaboration revenue$16K Total operatingexpenses$17,693K General andadministrative expense$6,583K Research and developmentexpense$11,110K

Connect Biopharma Holdings Ltd (CNTB)

Connect Biopharma Holdings Ltd (CNTB)